Oxford has remained a leader in the lending industry because of our commitment to remain fair, flexible and responsive to the changing needs of our clients. Furthermore, since opening our doors, we have been a stable and constant source of capital. Over the past few years, we have originated over $1.5 billion in loans to over 200 companies, with lines of credit ranging from $500 thousand to $50 million. Oxford is a portfolio company of Sumitomo Corporation ("Sumitomo") and Welsh, Carson, Anderson & Stowe ("Welsh Carson"). With assets exceeding $70 billion, Sumitomo is one of Japan's leading traders and distributors of commodities, industrial products and consumer goods. Welsh Carson is one of the largest and most successful private equity investment firms in the United States, focusing heavily on the healthcare industry. Since its inception, Welsh Carson has organized 15 limited partnerships with total capital of $20 billion.
Oxford Finance, headquartered in Alexandria, Virginia, is a specialty financial services firm that provides senior debt exclusively to life sciences and healthcare services companies worldwide. For over two decades, our management team has been delivering loans to some of the most innovative participants in this industry—such companies as Alnylam Pharmaceuticals, Supernus Pharmaceuticals, MAP Pharmaceuticals, Ardea Biosciences, Avanti Health Systems and Great Lakes Home Health and Hospice.
